These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29207937)

  • 21. Association of an emergency department febrile neutropenia intervention protocol with time to initial antibiotic treatment.
    Seltzer JA; Frankfurt O; Kyriacou DN
    Acad Emerg Med; 2022 Jan; 29(1):73-82. PubMed ID: 34245642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode.
    Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R
    Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis.
    Zhang D; Micek ST; Kollef MH
    Crit Care Med; 2015 Oct; 43(10):2133-40. PubMed ID: 26121071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.
    Pillinger KE; Bouchard J; Withers ST; Mediwala K; McGee EU; Gibson GM; Bland CM; Bookstaver PB
    Ann Pharmacother; 2020 Jun; 54(6):594-610. PubMed ID: 31771337
    [No Abstract]   [Full Text] [Related]  

  • 25. Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial.
    Lima SS; Nobre V; de Castro Romanelli RM; Clemente WT; da Silva Bittencourt HN; Melo AC; Salomão LC; Serufo JC
    Ann Hematol; 2016 Jun; 95(7):1169-76. PubMed ID: 27118539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
    Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
    J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with hospital length of stay among cancer patients with febrile neutropenia.
    Rosa RG; Goldani LZ
    PLoS One; 2014; 9(10):e108969. PubMed ID: 25285790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergency Ambulatory Management of Low-Risk Febrile Neutropenia: Multinational Association for Supportive Care in Cancer Fits-Real-World Experience From a UK Cancer Center.
    Marshall W; Campbell G; Knight T; Al-Sayed T; Cooksley T
    J Emerg Med; 2020 Mar; 58(3):444-448. PubMed ID: 31744709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk Factors for Microbiologically-documented Infections, Mortality and Prolonged Hospital Stay in Children with Febrile Neutropenia.
    Das A; Trehan A; Bansal D
    Indian Pediatr; 2018 Oct; 55(10):859-864. PubMed ID: 29941699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Febrile Neutropenia: Decreasing Time to Antibiotic Administration in a Community Hospital Emergency Department.
    Bruce SD
    Clin J Oncol Nurs; 2021 Feb; 25(1):23-26. PubMed ID: 33480869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy of cycling empirical antibiotic therapy for febrile neutropenia in pediatric cancer patients.
    Teranishi H; Koga Y; Nishio H; Kato W; Ono H; Kanno S; Nakashima K; Takada H
    J Infect Chemother; 2017 Jul; 23(7):463-467. PubMed ID: 28527651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
    Jeong SH; Kim DY; Jang JH; Mun YC; Choi CW; Kim SH; Kim JS; Park JS
    Ann Hematol; 2016 Jan; 95(2):337-44. PubMed ID: 26596974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N; El-Mahallawy HA; Ahmed IA; Nassif S; El-Beshlawy A; El-Haddad A
    Pediatr Blood Cancer; 2007 Nov; 49(6):786-92. PubMed ID: 17366527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Febrile Neutropenia in Children With Cancer Managed on an Outpatient Basis: A Report From Tertiary Care Hospital From a Resource-limited Setting.
    Meena JP; Gupta AK; Seth R
    J Pediatr Hematol Oncol; 2020 Nov; 42(8):467-473. PubMed ID: 32815874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Post chemoterapy febrile neutropenia. Length of stay and experience in our population].
    Pérez-Heras Í; Raynero-Mellado RC; Díaz-Merchán R; Domínguez-Pinilla N
    An Pediatr (Engl Ed); 2020 Mar; 92(3):141-146. PubMed ID: 31239190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
    J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study of the clinical and economic burden during hospitalizations among cancer patients with febrile neutropenia.
    Dulisse B; Li X; Gayle JA; Barron RL; Ernst FR; Rothman KJ; Legg JC; Kaye JA
    J Med Econ; 2013; 16(6):720-35. PubMed ID: 23452298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Antimicrobial Utilization among Cancer Patients with Febrile Neutropenia at the Lebanese Hospitals.
    Cherri S; Malaeb D; Shouman L; Fahs I; Hallit R; Hallit S; Malaeb B; Salameh P
    Curr Drug Saf; 2023; 18(4):496-503. PubMed ID: 35726429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.
    Ko BS; Ahn S; Lee YS; Kim WY; Lim KS; Lee JL
    Support Care Cancer; 2015 Sep; 23(9):2799-804. PubMed ID: 25663578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.